Navigation Links
SpineMark Partners With Regional Spine Leaders to Launch Its First Multisite Spine Research Organizations in Los Angeles, Denver
Date:4/9/2008

Model to be replicated throughout cities nationally

LOS ANGELES and DENVER, April 9, 2008 /PRNewswire/ -- SpineMark CRO Management, a wholly owned subsidiary of SpineMark Corporation, is collaborating with Los Angeles- and Denver-area physicians to create the nation's first multidisciplinary, multisite Spine Research Organizations (SRO), to unite the regions' leading spine experts under one organization. The SpineMark SROs will provide patients in their respective communities with access to the most advanced spine care therapies under research today, while offering the participating physicians and hospitals an unprecedented level of support and third-party resources experienced in clinical trial management.

"Many of us have wanted to offer our patients greater treatment options, but we've been limited by the amount of infrastructure necessary to participate in large, national trials," said Dr. Robert J. Bess, an orthopedic spine surgeon and co-founder of the SpineMark SRO of Denver. "By partnering with SpineMark, we are able to provide patients with the best of all worlds -- access to community practices that can provide quality, personalized care coupled with the clinical trial opportunities of larger facilities."

The SpineMark SROs, which include surgical specialists, interventional pain specialists and conservative care physicians, will provide a seamless, integrated path of care for patients needing spine treatment. SpineMark will work with medical device and pharmaceutical companies to recruit for FDA trials, coordinate with the SRO and provide quality assurance, as well as appropriate staff infrastructure for trial protocols, policies and procedures.

"Without SpineMark's support, we would not be able to participate in clinical trials evaluating the latest minimally invasive treatments for spinal disorders and injuries," said Dr. Perry Haney, an interventional pain specialist, and cofounder of the SpineMark SRO of Denv
'/>"/>

SOURCE SpineMark CRO Management
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Nektar Terminates All Negotiations With Potential Partners for Inhaled Insulin; Increased Number of Lung Cancer Cases Observed in Ongoing Clinical Studies of Inhaled Insulin Patients
2. Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2007 Financial Results
3. SpineSmith Partners to Present at 3rd Annual Stem Cell Summit
4. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
5. Catalyst Pharmaceutical Partners Begins Enrollment for Its U.S. Phase II Clinical Trial of CPP-109 in Patients with Cocaine Addiction
6. iCAD Announces Partnership for Initiating Clinical Testing of Its Virtual Colonoscopy CAD Product
7. HealthMedias Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships
8. UNICEF Partners With Causes on Facebook to Launch Charity Gift Feature
9. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
10. The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals
11. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... to Millennium Research Group (MRG), the global authority ... United States and European transcatheter embolization ... through 2022, with embolization particles representing one of ... drug-eluting beads (DEBs) and radioembolization spheres in interventional ...
(Date:1/15/2014)...  Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 ("HSR") ... its indirect wholly-owned subsidiary, Sapphire Subsidiary Corp. ("Purchaser"), for ... Solta Medical, Inc. (NASDAQ: SLTM ) ("Solta") ...
(Date:1/15/2014)... , Jan. 15, 2014  Zafgen, Inc., a leading ... of severely obese patients, today announced initial results ... selective inhibitor of methionine aminopeptidase 2 (MetAP2), in ... of genetic obesity.  These results showed improvements in ...
Breaking Medicine Technology:US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4
... England, July 29, 2011 , ... The UK bioindustry has raised over $250m in financing ... any quarter for one year, and the second largest amount raised ... to the financing drought that saw three consecutive quarters below $100m ...
... Health Company (Nasdaq: FHCO ) today announced that ... operating results for the third quarter and first nine months ... Eastern Time (EDT).  The Company expects to report its operating ... other interested parties may participate in the conference call by ...
Cached Medicine Technology:UK Chalks Up $253 Million in Investment in Q2 2011: Oxford Cluster Takes the Largest Bite of the Apple 2UK Chalks Up $253 Million in Investment in Q2 2011: Oxford Cluster Takes the Largest Bite of the Apple 3The Female Health Company to Host Third Quarter Conference Call on Friday, August 5, 2011 2
(Date:7/10/2014)... Texas (July 10, 2014) Men who experience hot ... they may find relief from their silent suffering ... according to findings from a Baylor University case study., ... man who had uncontrolled hot flashes following prostate cancer ... flashes but also an impressive improvement in sleep quality, ...
(Date:7/9/2014)... -- The World Health Organization recommends that youth participate ... vigorous physical activity (MVPA) each day. Studies have ... school hours. Therefore, it stands to reason that ... In a new study scheduled for publication in ... time spent outdoors after school was positively associated with ...
(Date:7/9/2014)... July 10, 2014 For the first time, researchers ... Aboriginal population in Canada uses health care. A new ... to clearly demonstrate the unique challenges faced by urban ... St. Michael,s Hospital. , The findings, published today ... urban First Nations individuals and the general population. , ...
(Date:7/9/2014)... of Medicine at the University of Pennsylvania in collaboration ... $8 million grant from the National Cancer Institute (NCI) ... in patients with malignant pleural mesothelioma, a rare, aggressive ... the lining of the lungs and is caused almost ... a clinical trial and additional studies looking at the ...
(Date:7/9/2014)... types of cancer sends the protein factories in our ... uncontrolled growth, new research suggests. , Scientists at The ... responsible for ratcheting up activity of the endoplasmic reticulum ... blocks cancer cells need to keep growing. , A ... the flow of messages to the endoplasmic reticulum telling ...
Breaking Medicine News(10 mins):Health News:Men's hot flashes: Hypnotic relaxation may ease the discomfort men don't talk about 2Health News:Men's hot flashes: Hypnotic relaxation may ease the discomfort men don't talk about 3Health News:Men's hot flashes: Hypnotic relaxation may ease the discomfort men don't talk about 4Health News:Go play outside! Outdoor time promotes physical activity in youth 2Health News:Urban Aboriginal people face unique health challenges 2Health News:Penn mesothelioma program receives $8 million NCI grant 2Health News:Signal may send cancer's cellular factories into overdrive 2
... the current standard of care to treat opioid-dependent ... findings from an international team led by Johns Hopkins ... the New England Journal of Medicine . ... to counter heroin and/or prescription opioid addiction were likely ...
... Steven Reinberg HealthDay Reporter , THURSDAY, Dec. 9 ... on a new trick for weight loss: To eat less ... it up beforehand. Repeatedly imagining the consumption of a ... lead researcher Carey Morewedge, an assistant professor of social and ...
... of Cincinnati (UC) and Massachusetts General Hospital have ... may not be as beneficial to some patients ... findings were published online this week ahead of ... and Outcomes . Warfarin is commonly ...
... A genetic mutation associated with an inherited form of Lou ... lateral sclerosis (ALS) -- has been identified by an international ... are hereditary. In their study, the team used a ... the mutation in the valosin-containing protein (VCP) gene, which has ...
... (HealthDay News) -- Only 50 percent of women over age ... screen for breast cancer, even if they have insurance to ... a database of more than 12 million people to review ... the women included in the study had either employer-provided insurance ...
... of melanoma tumors by targeting the MIC-1 protein that ... better treatment of this invasive and deadly cancer, according ... Foreman Foundation Research Laboratory. , "Preventing vessels from developing ... growing," said lead author Gavin Robertson, Ph.D., professor of ...
Cached Medicine News:Health News:Buprenorphine is better than methadone for opioid dependence in pregnant women, study shows 2Health News:Mental Imagery a New Weight-Loss Tool? 2Health News:Mental Imagery a New Weight-Loss Tool? 3Health News:Blood-thinning treatment standards changing for heart patients, new research shows 2Health News:Blood-thinning treatment standards changing for heart patients, new research shows 3Health News:Only Half of Women Over 40 Get Annual Mammograms 2Health News:Protein targeted to stop melanoma tumor growth 2
... for the mid- to high-volume lab, the ... can reduce time-consuming manual tasks by as ... performs random access, STAT, HCFA panels and ... including Stat chemistries, General chemistries, TDMs, DATs, ...
... It takes powerful technology to ... safety, and still lower costs. ... LX20 PRO, offering features that ... any other chemistry analyzer, including ...
... This user-friendly instrument ... Plasma Protein analyzer for ... It is a well ... reliable results for a ...
For Detection of Bile Component in Reflux Disease...
Medicine Products: